<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39-vaccines-07-00053">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gao</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Duan</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Xing</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge</article-title>
  <source>Antiviral Res.</source>
  <year>2013</year>
  <volume>98</volume>
  <fpage>4</fpage>
  <lpage>11</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2013.01.010</pub-id>
  <pub-id pub-id-type="pmid">23416215</pub-id>
 </element-citation>
</ref>
